The US Food and Drug Administration (FDA) has approved Atzumi, a 5.2 mg dihydroergotamine (DHE) nasal powder, for the acute ...

WITH the arrival of summer comes the dreaded hay fever season for many. But relief doesn’t have to break the bank.  Switching ...

The FDA has approved Atzumi (dihydroergotamine) nasal powder for the acute treatment of migraine with or without aura in adults.

SACRAMENTO – Governor Newsom announced that individual twin-packs of CalRx®-branded over-the-counter (OTC) naloxone HCL 4 mg nasal spray are now available to all Californians at a low price of $24 per ...

The Trump administration has proposed terminating a $56 million annual grant program that distributes naloxone, also known by ...

DHE is a migraine-specific acute medication first approved in 1946. The FDA's approval of the nasal powder formulation, ...

Trump has been using the "Fentanyl Crisis"* as justification for instituting a police state. The more fentanyl deaths, the worse the crisis seems, allowing him to implement even harsher actions. * ...

California is making progress in curbing fentanyl-related deaths, but opioid overdoses continue to kill thousands of people ...

Akita Biosciences, Inc., a consumer health company that develops innovative nasal spray formulations for drug, device, and cosmetic applications, has received a grant from Flu Lab to evaluate the ...

An antidepressant containing a form of the drug ketamine has been added to the Pharmaceutical Benefits Scheme (PBS), making ...

A nasal spray that's having life-changing impacts on people living with depression is set to be listed on the PBS, slashing ...

The federal government has bankrolled the use of an artificial ketamine nasal spray to combat treatment-resistant depression, ...